Both Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs allow US-owned and operated small businesses to engage in federal research and development that has a strong potential for commercialization. A key objective is to translate promising technologies to the private sector and enable life-saving innovations to reach consumer markets.
The NIH SBIR program funds early stage small businesses that are seeking to commercialize innovative biomedical technologies. This competitive program helps small businesses participate in federal research and development, develop life-saving technologies, and create jobs.
The NIH STTR program is similar to the NIH SBIR program, but requires that the small business formally collaborate with a research institution in Phase I and Phase II.
Learn more about NIGMS’s interest in the SBIR and STTR programs:
This page last reviewed on
4/20/2020 2:55 PM
Connect With Us: